156 related articles for article (PubMed ID: 4886576)
1. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
Bonnyns M; Vanhaelst L
J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
[No Abstract] [Full Text] [Related]
2. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
Adlkofer F; Schleusener H; Uher L; Ananos A
Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
[No Abstract] [Full Text] [Related]
3. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
Mori T; Fisher J; Kriss JP
J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
[No Abstract] [Full Text] [Related]
4. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
[No Abstract] [Full Text] [Related]
5. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
6. Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.
Burke G; Silverstein GE
JAMA; 1969 Nov; 210(6):1051-8. PubMed ID: 4900342
[No Abstract] [Full Text] [Related]
7. Thyroid-stimulating immunoglobulins in Graves' disease.
Smith BR; Hall R
Lancet; 1974 Aug; 2(7878):427-31. PubMed ID: 4137321
[No Abstract] [Full Text] [Related]
8. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
[No Abstract] [Full Text] [Related]
9. Neonatal transient thyrotoxicosis resulting from maternal TSH-binding inhibitor immunoglobulins.
Yagi H; Takeuchi M; Nagashima K; Suzuki S; Kuroume T; Iida Y; Konishi J; Endo K
J Pediatr; 1983 Oct; 103(4):591-3. PubMed ID: 6137525
[No Abstract] [Full Text] [Related]
10. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
Orgiazzi J; Pousset G; Durand H
Presse Med (1893); 1971 May; 79(25):1167-8. PubMed ID: 4933634
[No Abstract] [Full Text] [Related]
11. Long-acting thyroid stimulator in thyrotoxic monozygous twins.
Priest WM
Br Med J; 1970 Jul; 3(5716):205. PubMed ID: 5311030
[No Abstract] [Full Text] [Related]
12. Editorial: hyperthyroidism and Grave's disease.
Br Med J; 1975 May; 2(5969):457-8. PubMed ID: 1173788
[No Abstract] [Full Text] [Related]
13. Ophthalmic Graves' disease. Diagnosis and pathogenesis.
Hall R; Kirkham K; Doniach D; el-Kabir D
Lancet; 1970 Feb; 1(7643):375-8. PubMed ID: 4189686
[No Abstract] [Full Text] [Related]
14. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
Földes J; Takó J; Bános C; Gesztesi E; Varga I
Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
[No Abstract] [Full Text] [Related]
15. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
Tourneur R; Letonturier P; Sénécal P
MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
[No Abstract] [Full Text] [Related]
16. Radioimmunological studies on the long-acting thyroid stimulator.
Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
[No Abstract] [Full Text] [Related]
17. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
Wong ET; Doe RP
Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
[No Abstract] [Full Text] [Related]
18. Humoral immunity in Graves' disease.
McKenzie JM; Zakarija M; Sato A
Clin Endocrinol Metab; 1978 Mar; 7(1):31-45. PubMed ID: 580600
[No Abstract] [Full Text] [Related]
19. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
Letonturier P; Tourneur R; Sénécal P
Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
[No Abstract] [Full Text] [Related]
20. Long-acting thyroid stimulator and thyroid function in relatives of patients with Graves' disease.
Bonnyns M; Vanhaerlst L; Golstein J; Cauchie C; Ermans AM; Bastenie PA
Clin Endocrinol (Oxf); 1973 Jul; 2(3):277-87. PubMed ID: 4128244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
